Linjie Dong
Biographic Data
| ID | 7309615 |
|---|---|
| NAME | Linjie Dong |
| GIVEN NAMES | Linjie |
| FAMILY NAME | Dong |
| SIGNATURE | DONG L |
| AFFILIATIONS | Shenyang Pharmaceutical University |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation
The key pharmacodynamic material basis of XKF, such as berberine and its metabolites (berberrubine and demethyleneberberine), chlorogenic acid and its metabolites (3-O-feruloylquinic acid and 5-O-feruloylquinic acid), calycosin and swertiamarin influence the glucose metabolism disorder of IR-HepG2 cells by regulating the PI3K/AKT signalling pathway, leading to an improvement in IR
No prominent works on this page.
Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation
The key pharmacodynamic material basis of XKF, such as berberine and its metabolites (berberrubine and demethyleneberberine), chlorogenic acid and its metabolites (3-O-feruloylquinic acid and 5-O-feruloylquinic acid), calycosin and swertiamarin influence the glucose metabolism disorder of IR-HepG2 cells by regulating the PI3K/AKT signalling pathway, leading to an improvement in IR
Berberine (1 works) · Berberine and alkaloids research (1 works) · Biochemistry (1 works) · Bioinformatics (1 works) · Biology (1 works) · Chemistry (1 works) · Chromatography in Natural Products (1 works) · Endocrinology (1 works) · Insulin (1 works) · Insulin receptor (1 works)